• Creator
    Topic
  • #67
    FEAT BC Admin
    Keymaster

    This area is for discussions in general topics.

Viewing 10 replies - 2,061 through 2,070 (of 3,469 total)
  • Author
    Replies
  • #4222
    Mike & Jean
    Participant

    Due to Spring Break, there will not be a F.E.A.T. meeting in March.

    The next F.E.A.T. meeting will be on Monday, April 11th. Details will by posted during the first week of April.

    Jean

    #4223
    Barbara Rodrigues
    Participant

    Regarding the Dr. Peter Gerhardt conference – I just heard from someone that he will most likely be doing another workshop up here in Vancouver at UBC in October – so for those interested and in terms of cost saving you might want to attend that one. Will post more when confirmed for those interested.

    Barbara

    #4224
    Deleted User
    Member

    I share your frustration David. But let me just say to everyone, all the MORE reason to attend workshops such as this in the U.S. We must learn about laws such as those in the U.S. because the onus is on us to force the political powers to create similar laws here. I think we have all learned that no one will save our children just because it is the right thing to do. No, we must force them to do what is right.

    Surround yourself with information on what it should be, what it could be. Get frustrated because it will motivate you to say THIS IS NOT GOOD ENOUGH!

    As frustrating at it is Non illigitamus carborundum (Don't let the bastards grind you down)

    #4225
    David Chan
    Member

    Hi folks,

    First of all I would like to say that it was an awesome conference
    on Saturday. Dr. Freeman, Dr. Newman, and Dr. Gerenser. (we
    found out she just finished her PhD) were icredible speakers. It
    certainly lit a fire under my behind, and also it was a great
    reinforcer for our family, after all we are all behaviouralist here.

    Having said that, I will move on to my next point.

    Thank you DeeDee for posting the info on the FEAT confernce in
    Seattle with Dr. Peter Gerhardt. It's quite a coincidence that Dr.
    Newman had mentioned Dr. Gerhardt in his talk as well. So I
    promptly went to the FEAT of Washington site, and looked up
    the conference. the intro read as follows:

    "Increasingly, attetion is being paid to needs of learners with
    Autism Spectrum disorder (ASD) as they enter adolescences and
    grow into adulthoodl. Bouyed by the transition requirements of
    IDEA and equal access legislation such as the Americans with
    Disabilites Act, professionals, families and learners with ASD are
    beginning to reconceptualize the transition process in terns of
    personal competence, satisfaction beyond the classroom; and
    not simply in terms of vocational training. Where job placement
    was once considered desirable, now the goal is career
    development. In place of residential placement, we are no
    beginning to talk about residential choices in support of qulity
    of life"

    And it goes on to describe the content of the workshop.

    The more I read, the more angry I got. I came to the realization
    that for us here in British Columbia going to a workshop is that
    discuss issues the above described is simple folly. Why ?
    Because we have NO LEGISLATION like the IDEA (indiviuals with
    disabilties education act) and the ADA (Americans with
    disabilites act) to back up any kind of implementation that we
    learn about in that workshop. Let me extend that point further
    by saying that attending any kind of workshop and conference is
    simply painful to the extreme because you see what is possible,
    and you KNOW even if you mortgage the farm to help your kid,
    the rest of his world does not have LEGISLATION to support him,
    so it is all for nought.

    I for one am not a masochist. my life is painful enough not to
    have to see what could possibly be done elsewhere.

    Yeah, I am pi@*ed, Going to a conference isn't good enough any
    more. That's like getting cancer and having some one TELL you
    about Chemotherapy, but oh by the way it works really well but
    you can't have it.

    Oh, Why I can't I have it, because our goverment gives you a
    choice and options in treatment.

    I honestly think that if we subtitute the neurological disorder of
    Autism with Diabetes, or Heart Disease, or Cancer, as a
    community we would set our hair on fire. And yet here we have
    our children.

    What's the point of this rant. Get angry, get excited, I know it's
    hard to be politically active while you are running your program
    for your kid or kids. It's a lot to ask. Get to a FEAT meeting, go
    and get a petition from canadaautism.com. Just get plain
    Pi@#ed off, and do something. We need to make LAWS to protect
    the most vulnerable in our society, OUR CHILDREN.

    Regular folks have NO IDEA of what our families have sacrificed
    so that our children would have the proper, science-based
    intervention. Well, now is the time.

    And for you folks with kids 6 and under. As sure as the sun
    rises, that child WILL be 7, then what ?

    As for me. Confernces are academic. Our family life is real. We
    will as before carry on the good fight.

    For all of you fighting the good fight

    We shall over come. We have no choice

    Dave
    Mr. P's Dad

    #4226
    Mike & Jean
    Participant

    There are a couple of other parents whose contributions to the success of the Autism Treatment conference that I forgot to recognize in my previous post. Avery Raskin and Nancy Walton, both are long time "veterans" whose contributions to the movement have been and continue to be very significant. Thankyou both! And thankyou to everyone else who are unamed here but work tirelessly in the service of others.

    Jean

    #4227
    Deleted User
    Member

    FEAT of Washington

    presents

    Peter Gerhardt, EdD*

    Transition Programming for Adolescents and Adults with ASD

    April 23, 2005

    9:00am – 4:30pm

    University Christian Church

    4731 15th Ave. NE (Cor. 15th & 50th)

    Seattle, WA

    Increasingly, attention is being paid to needs of learners with Autism Spectrum Disorder (ASD) as they enter adolescence and grow into adulthood. Buoyed by the transition requirements of IDEA and equal access legislation such as the Americans with Disabilities Act, professionals, families and learners with ASD are beginning to reconceptualize the transition process in terms of personal competence and satisfaction beyond the classroom; and not simply in terms of vocational training. Where job placement was once considered desirable, now the goal is career development. In place of residential placement, we are now beginning to talk about residential choices in support of quality of life.

    This workshop will provide an overview of this movement toward transition planning for competent adulthood. In addition to employment support, attention will be paid to instructional support in the areas of social skills, leisure, sexuality, and quality of life.

    *About Peter Gerhardt, Ed.D.

    Dr. Gerhardt has over 20 years experience working with learners with autism spectrum disorders (ASD) in educational, vocational and/or community settings. He is the author and co-author of articles and book chapters on the needs of adults with ASD, the school-to-work transition process and analysis and intervention of problematic behavior. He has presented nationally and internationally on these topics.

    He is currently in private practice and is the Chairperson of the Scientific Council of the Organization for Applied Research (OAR). He is a member of the Advisory Board of several organizations including QUEST Autism Foundation, Queens Services for the Autism Community (QSAC), NJ Council of Outreach and Services to the Autism Community (COSAC), and the Autism Society of America.

    Previously Dr. Gerhardt was the Director of the Nassau Suffolk Services for Autism which operates the Martin C. Barrell School in Levittown, NY. He was also a Research Assistant Professor at the Rutgers University Graduate School of Applied and Professional Psychology with an appointment as the Director of the Division of Transition and Adult Services of the Douglass Developmental Disabilities Center. It was in this capacity that he co-founded the Douglass Group, a social skills and support service for adults with Aspergers Disorder or High Functioning Autism.

    Dr. Gerhardt received his doctorate from the Rutgers University Graduate School of Education.

    Bonus Speaker (1:00-2:00 PM):

    Connie Frenzel, R.N., M.S.

    ATP Outreach Coordinator

    National Alliance for Autism Research

    THE AUTISM TISSUE PROGRAM:FROM HOPE TO PROGRESS IN BRAIN RESEARCH An update on what brain tissue research is revealing about differences in the brain and how these differences relate to behaviors, language disruption, social challenges, seizures and genetics

    Connie is the parent of a 17 yr old with autism and brings an extensive public health nursing background and parent advocacy experience to the program. She founded and directed a home health agency, was a clinical professor in public health nursing, and has authored several articles in gerontology and autism journals.

    $65 — FEAT Members

    $80 — non-FEAT members

    Call 206.763.3373 or email the FEAT office featwa@featwa.org for a registration form

    or visit the website http://www.featwa.org

    – Registration & continental breakfast begins at 8:00am
    – Box lunches provided at noon

    #4228
    Mike & Jean
    Participant

    Hi everyone! I just wanted to thank all the volunteers who worked so hard to produce and present, "Autism Treatments: What's Science Got to do With it?"

    It was a great conference! Our speakers; Sabrina Freeman, Bobby Newman and Joanne Gerenser had great presentations! We had a wonderful turn-out of just over 250 people.

    Once again, thankyou to all the volunteers but particularly, Debbie Rees, Andrea Finch, Jennifer Ralph, Eva Lee, Tamara Leger, Marie Gauthier, Jennifer Weatherbee, David Chan. OUr parent panel: Bev Sharpe, Maureen Lundell, Pam Mihic, Michelle Karren, Justin Himelright and Judy Anderson. The "Island Girls – Barb, Yvonne, Megan and the rest; Amy Stevenson, Julie Clemens. There are more but I don't have everyone's names. Thankyou all for making today such a wonderful success!

    Jean

    #4229
    Leah Mumford
    Participant

    Hi Debbie:

    with all the kids that I've worked with, the SLP's and OT's all say counter-clockwise, even though it seems a bit awkward. They say that when kids start writing letters, (e.g., "c" "o" "d"), the round parts are written counter-clockwise to be formed properly.

    hope that helps,
    Leah

    #4230
    Debbie
    Member

    hello there to all, i am wondering if any can clue me in as to what way a circle should be drawn,should it be clock wise or counter clockwise,,,we want to teach my son one way and the schools seem to do it a different way, what is the protocol,,,,,, i have spoken with my senior about this,,,,,,,so i am just wanting anybody's opinion as to what they have done,,,,and thanx for your help,,,,,
    debbie,
    dj's mom

    #4231
    Sabrina Freeman
    Participant

    Regarding the "Fluency" model of autism
    treatment, Dee-Dee Doyle posits that we
    should all, "open [our] minds to ABA treatment
    and methods supported by single subject
    research and all that it can offer our children
    with autism."

    This view of autism treatment research begs
    the question: is single-subject research
    design truly a valid means of establishing the
    efficacy of an autism treatment for a
    population of children with autism, as
    opposed to the treatment needs of only a
    single child? I thought I'd share some
    thoughts on the single-subject case design in
    autism treatment, for those of you who may be
    interested.

    What is a Single-Subject Case Design?

    A single-subject research design (SSRD) is
    simply an experiment that uses one subject.
    I'm certain almost every parent of a child with
    autism has seen of or heard of this kind of
    design. It is very common in autism research.
    Not only is it common amongst the kooks; it is
    also very common amongst legitimate
    clinicians. In fact, the vast majority of studies
    done in the field of applied behavior analysis
    are single-subject case designs. In addition,
    in rehabilitation research it is used often,
    particularly by Occupational Therapists and
    Physiotherapists. The reason for this is that
    single-subject research is ideally suited when
    there is a patient with an injury, for example,
    and the treatment plan for the person is
    individualized. Remember, in this case, the
    goal is to rehabilitate that one patient; the goal
    is not to generalize that treatment plan to other
    patients, or a population of patients with the
    same diagnosis.

    Before I explain this kind of research, I need to
    let you all know that researchers who do this
    type research often feel that they are under
    attack from the scientific community, and there
    is an ongoing debate as to how this kind of
    research should be used. That said, I think it
    is fair to say that there is consensus in
    science that single-subject research is useful
    in a clinical setting, but it's absolutely not
    appropriate to generalize from one
    single-subject research design to the
    population at large, which unfortunately
    happens in autism research — a lot!

    There are advantages to single-subject
    research designs. The first is that the
    experimenter uses the person as his own
    control by comparing data from before the
    treatment, and immediately after the
    treatment. This removes all the possible
    errors that can flow from random, individual
    differences amongst people, since it is the
    same person in the study. In fact, this design
    typically observes behavior, for example, on
    five different occasions before introducing the
    treatment. Then, many researchers in SSRD
    will use statistical analyses to ensure that
    there is a true difference between the before
    treatment and after treatment data. Many
    researchers don't use statistics to see the
    results; they simply look at a graph showing
    the data points before and after. Even those
    using statistics are criticized because there is
    a debate about which statistical tests are
    appropriate to use. These researchers claim
    that SSRD is actually better because the
    internal validity is high. Here they are referring
    to the idea that there is no variability between
    children in the control and experimental
    groups since the control and the treatment are
    done on the same person. In other words, as
    mentioned above, there is no difference
    between children because there is only one
    child who is measured before and after.

    A hypothetical design example shows a child
    who enters treatment for 6 months and then is
    given an I.Q. test. Then the child is not given
    treatment for a year and his I.Q. is measured.
    Then the child goes into treatment for another
    6 months and his I.Q. is measured. Then the
    child is taken out of treatment for another year
    and his I.Q. is again measured. From this
    kind of design, one could clearly see whether
    the child was benefiting from treatment, and if
    the child was regressing when not in
    treatment. For that ONE child, it appears as
    though treatment is having a very strong effect.
    For clinical decisions, the single-subject
    design looks very compelling since we are not
    generalizing to the population at large; rather,
    we are simply making a clinical decision as to
    whether that child is benefiting from the
    treatment. When single-subject designs are
    used in that manner, they do a true service to
    the child.

    This is particularly true with autistic individuals
    with self-injurious behavior. If a clinician uses
    techniques to eliminate self-injurious
    behavior, do we really care about the fact that
    there was only one child in the study?
    Obviously not. We care only that this treatment
    worked for this individual and has now given
    him a life where he is not restrained, but
    rather, can go out into the community with his
    family. When these kinds of studies are
    published, they are incredibly beneficial to
    other clinicians as new and valuable tools in
    the kit box for use when presented with a
    self-injurious client.

    SSRD's are also very useful to motivate
    different kinds of research to determine
    causal relationships. In fact, a small
    within-subject design using 2 children actually
    motivated Lovaas to do a large-scale
    between/within subject design, which became
    a very well known experiment published in
    1987.

    To summarize single subject research
    design:

    – Study using only 1 child with autism in the
    entire study
    – Common in autism research
    – Useful in a clinical setting
    – Controversial research design if used
    improperly

    What's the Problem with Single-Subject Case
    Designs?

    There is no problem with the single-subject
    design when it is used properly; however, it is
    used improperly in autism treatment research
    all the time. It is used heavily by quacks
    because it is cheap and easy. Quacks only
    need to find one child on which to
    "experiment," and then a poor single-subject
    case design can morph into an anecdote-now
    -dressed-up-as-genuine-research.

    Another problem amongst some researchers
    is that they claim single-subject design can
    show that A causes B in general. Under
    certain conditions, it's fine to say that a child
    improved due to the treatment if proper
    measurements have been taken. When this
    happens, the "Therapeutic Criterion" or the
    treatment value for the subject has been met.
    Unfortunately, from that one child, one cannot
    make general statements about how effective
    the treatment was. This is called the
    "Experimental Criterion." The "Experimental
    Criterion" has not been met from one or two or
    even three experiments. I think it is safe to say
    that single-subject designs are one very
    valuable way to probe and see if it is
    worthwhile to create a between-subjects
    experiment with a larger number of children
    (as in the Lovaas's research) if indeed we
    want to generalize results to the larger
    population of children with autism.

    Proponents of the single-subject case design
    argue that the solution to the generalizability
    problem is to do many replications, and in this
    way show that the result can be generalized to
    the population of children with autism. They
    would say that their study is just as good as
    between-subject designs in terms of
    generalization, as long as both types of
    studies can replicate their results.

    They are also proponents of meta-analyses.
    In a meta-analysis, the researcher combines
    the results of a number of single-subject
    studies to discern whether a given treatment
    is effective. This is difficult to do well, and has
    some methodological problems associated
    with it, but it is a much better way to add to the
    body of knowledge in autism research than
    generalizing through only one, single-subject
    research design — a definite no-no.

    Other critics, such as a researcher by the
    name of Furedy, are completely against the
    use of this type of design. He says: "The
    'single-subject' design (which really denotes a
    design that employs too few subjects to allow
    statistical inferences concerning significance
    to be made) is useful only for the generation,
    but not for the testing or evaluation, of
    hypotheses concerning any psychological
    functions." That's a fancy way of saying that
    there are not enough children in the study to
    make sure that the effect is real, and that the
    proper use of the single subject research
    design is to generate interesting ideas to test.

    Although we are not going to end the long
    running debate regarding the merits of
    single-subject designs in autism treatment
    any time soon, it is safe to say that there are
    too many methodological problems
    associated with this type of research design to
    rely upon its results as an autism treatment
    protocol that can be generalized to the
    population at large.

    It is my opinion that single-subject designs
    are relied upon far too heavily in autism
    research–again, often by quacks. The main
    point to take away from this discussion is this
    (and you can "take this to the bank"): it is not
    scientifically valid to generalize any given
    autism treatment protocol to the population at
    large from a single-subject design. So please
    be careful!

    Sabrina (Miki's Mom)

Viewing 10 replies - 2,061 through 2,070 (of 3,469 total)
  • You must be logged in to reply to this topic.